The findings focus on separate strategies, ranging from a mechanical cell receptor to a blood-based gel and a brain hormone.

Osteoporosis weakens bones and makes them more likely to break. The disease affects about 10 million Americans over age 50, ...

A one-time infusion of sugar-tagged bone marrow cells cut fragility fractures 94% in an osteoporosis trial, pointing toward a potential bone-regeneration treatment.

A Q&A with Dennis Black, PhD, professor of epidemiology and biostatistics at UCSF, who co-led a 13-year research project behind a landmark decision by the FDA that's accelerating drug development for ...

Back pain is often treated as a problem that comes with ageing, but new research suggests that some forms of spinal degeneration may have specific biological trigger, and an existing osteoporosis drug ...

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has uncovered a key biological mechanism that explains how ...

The US Food and Drug Administration (FDA) on Monday issued new draft guidance calling for drugmakers to conduct long-term nonclinical bone quality studies for osteoporosis treatments. According to FDA ...

Osteoporosis weakens bones and makes them more likely to break. The disease affects about 10 million Americans over age 50, ...

A team of FIU drug development scientists found a possible new way to counteract the effects of the disease that turns bones into honeycomb-like structures — so fragile even a cough can cause a ...

Please provide your email address to receive an email when new articles are posted on . Bone mineral density decreased in patients regardless of treatment with disease-modifying antirheumatic drugs.